International AGD Database; Determinants of AGD and Establishment of Normative Data
Launched by RIGSHOSPITALET, DENMARK · Jul 13, 2015
Trial Information
Current as of July 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Introduction Increasing incidence of cryptorchidism, hypospadias, and testicular cancer has paralleled the concomitant decline in male fertility in several countries(1). Exposures of environmental agents, which act as endocrine disruptors resulting in abnormalities in the development and function of fetal tests, have been hypothesised to underlie these trends. However, these outcomes are relatively rare, and in some cases occur a long period after exposure. Development of a sensitive biomarker of fetal androgen action during infancy is critical to evaluate the effects of potential endocrine...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects from populationbased cohort studies measuring AGD
- Exclusion Criteria:
- • none
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Anders Juul, prof
Principal Investigator
Rigshospitalet, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials